There were reductions in influenza cases, deaths, and costs by adding pharmacies during influenza epidemics.
Fewer than half of women who were pregnant during peak influenza vaccination period in 2017 to 2018 were vaccinated.
Influenza-related hospitalizations were reduced by 40% over 6 flu seasons.
Larger cities with higher base transmission potentials have more diffuse influenza epidemics.
Repeated exposure to the influenza virus affects antibody quantity and quality, and strains selected for seasonal vaccines may not provide coverage sufficient for individuals frequently infected and/or vaccinated.
Elderly patients who have been inoculated with the influenza vaccine and who also use a statin are at a greater risk for medically attended acute respiratory illness.
NasoVAX, an adenovirus-based intranasal flu vaccine, shows tolerability, safety, and higher cellular immune response compared to an injectable vaccine.
When compared to placebo, baloxavir marboxil was associated with reduced risk of influenza complications and faster recovery.
Active Choice Intervention Effective in Increasing Influenza Vaccination Rates at Primary Care PracticesOctober 08, 2018
Influenza vaccination rates decline as the clinic day progresses.
Patients with acute respiratory distress syndrome and confirmed influenza diagnosis treated ≤6 hours with oseltamivir had reduced length of hospital stay and a lower rate of mortality.
Wide variations in influenza vaccine coverage have been noted across healthcare personnel based on occupation and worksite.
The 2017 to 2018 flu strains hit the very young and elderly especially hard.
Mandatory genetic testing may also constitute an undue threat to employee autonomy and privacy.
Vaccination rates decreased throughout the day; with intervention, there was a similar increase throughout day.
New York City health officials say passengers had influenza or other common cold viruses.
Corticosteroids should not be used concomitantly with antiviral therapy in patients with influenza pneumonia.
According to the Centers for Disease Control and Prevention (CDC), the 2017-2018 flu season was one of the most severe - excluding pandemics - on record.
Baloxavir had a median time to alleviation of symptoms vs placebo, and a similar alleviation time as oseltamivir.
Influenza proved to be an independent risk factor for invasive pulmonary aspergillosis.
In general, routine annual vaccination is recommended for all patients ≥6 months of age who have no contraindications.
Hospitalization risk was also reduced for RA patients who received influenza vaccination.
Inappropriate antibiotic prescriptions were highest among urgent care facilities (45.7%), with emergency departments (24.6%), medical offices (17.0%), and retail clinics (14.4%) following.
Immune priming with seasonal H1N1 viruses earlier in life and egg-adaptation in vaccines can impact antibody responses following influenza vaccination.
Most children who died of pneumococcus and Haemophilus influenzae type b presented with pneumonia.
The New Drug Application for baloxavir marboxil is supported by results from the Phase 3 CAPSTONE-1 study (N=1436) which examined the effects of a single dose of baloxavir marboxil vs placebo or oseltamivir 75mg twice daily for 5 days.
Respiratory pathogens were associated with an increased risk for treatment failure in children with asthma exacerbations.
The researchers argued that outpatient antibiotic stewardship efforts must be strengthened to eliminate antibiotic treatment for viral upper respiratory infections and acute bronchitis.
The advisory comes early as physicians are currently placing vaccine orders.
A high impact was seen, especially when the vaccine uptake was optimally distributed across age groups.
This updated Committee Opinion includes more recent data on the safety and efficacy of influenza vaccination during pregnancy, as well as recommendations for treatment and postexposure chemoprophylaxis.